You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
First-in-class IL-15 receptor agonist nabs FDA approval for bladder cancer
|
|---|---|
| Published by |
Nature Reviews Drug Discovery, April 2024
|
| DOI | 10.1038/d41573-024-00073-9 |
| Pubmed ID | |
| Authors |
Asher Mullard |
X Demographics
The data shown below were collected from the profiles of 46 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | 17% |
| United Kingdom | 2 | 4% |
| Peru | 1 | 2% |
| China | 1 | 2% |
| Brazil | 1 | 2% |
| Canada | 1 | 2% |
| Japan | 1 | 2% |
| Jordan | 1 | 2% |
| Turkey | 1 | 2% |
| Other | 0 | 0% |
| Unknown | 29 | 63% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 70% |
| Scientists | 11 | 24% |
| Practitioners (doctors, other healthcare professionals) | 3 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 5 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 5 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 3 | 60% |
| Student > Master | 1 | 20% |
| Unknown | 1 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 3 | 60% |
| Immunology and Microbiology | 1 | 20% |
| Unknown | 1 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 26. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 May 2024.
All research outputs
#1,535,822
of 26,139,724 outputs
Outputs from Nature Reviews Drug Discovery
#740
of 3,736 outputs
Outputs of similar age
#20,671
of 320,623 outputs
Outputs of similar age from Nature Reviews Drug Discovery
#13
of 59 outputs
Altmetric has tracked 26,139,724 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,736 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,623 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.